Association of fasting plasma glucagon with osteopenia/osteoporosis in Chinese patients with type 2 diabetes. [PDF]
BMC Endocr DisordZhang L, Zhang P, Shi R.
europepmc +1 more source
Glucagon-like peptide-1 receptor (GLP-1R; GLP1R); glucagon receptor (GCGR); glucose-dependent insulinotropic polypeptide receptor (GIP receptor) [PDF]
Science-Business eXchange, 2013 openaire +1 more source
Glucagon-Like Peptide-1 Receptor Agonists as a Non-surgical Alternative to Bariatric Surgery for Weight Loss: A Review. [PDF]
CureusSteven C +7 more
europepmc +1 more source
Characterizing ghrelin's role in dysregulating GLP-1-mediated function and promoting the development of alcohol-associated liver disease. [PDF]
Biomed PharmacotherMahalingam S +10 more
europepmc +1 more source
Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control. [PDF]
Front Endocrinol (Lausanne)Lee SH, Park HY, Yun JH, Do EK.
europepmc +1 more source
Peptide YY in Type 2 Diabetes: A Complementary Gut Hormone with Therapeutic Potential Beyond GLP-1. [PDF]
NutrientsNguyen NT, Park JH.
europepmc +1 more source
Pharmacological therapies for type 2 diabetes: future approaches. [PDF]
DiabetologiaBailey CJ.
europepmc +1 more source
Amylin Revisited: A 5-Year Perspective on Its Emerging Role in the Treatment of Diabesity. [PDF]
J Obes Metab SyndrChung CW, Kim J.
europepmc +1 more source
Signaling architecture of the glucagon-like peptide-1 receptor. [PDF]
J Clin InvestAustin G, Tomas A.
europepmc +1 more source
Activating Muscarinic Receptor Signaling in Intrapancreatic Neurons Is Required for Parasympathetic Cholinergic Control of Pancreatic Cell Function. [PDF]
DiabetesLevi NJ +4 more
europepmc +1 more source